Teva Pharma (TEVA) Tops Q1 EPS by 11c
Get Alerts TEVA Hot Sheet
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) reported Q1 EPS of $1.36, $0.11 better than the analyst estimate of $1.25. Revenue for the quarter came in at $5 billion versus the consensus estimate of $4.84 billion.
For earnings history and earnings-related data on Teva Pharma (TEVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Surf Air Mobility Inc. (SRFM) Reports revenue, provides guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!